Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Gerosa

Showing results (81-90 of 120) with videos related to

Pageof 12
Sort By:
Frontiers in Immunology|May 18, 2026
Anti-β2GPI IgG display a broad reactivity against different β2GPI domains beyond domain 1: results from the APS ACTION and multi-center Italian cohortsClaudia Grossi, Caterina Bodio, Suresh Kumar, et al.
Frontiers in Immunology|April 27, 2026
Correction: A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registryAlexander Pine, Ayesha Butt, Laura Andreoli, et al.
Frontiers in Immunology|November 3, 2025
A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registryAlexander Pine, Ayesha Butt, Laura Andreoli, et al.
Frontiers in Immunology|June 11, 2026
Correction: Anti-β2GPI IgG display a broad reactivity against different β2GPI domains beyond domain 1: results from the APS ACTION and multi-center Italian cohortsClaudia Grossi, Caterina Bodio, Suresh Kumar, et al.
Arthritis Care & Research|April 19, 2018
The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and RepositoryOzan Unlu, Doruk Erkan, Medha Barbhaiya, et al.
Lupus Science & Medicine|June 14, 2022
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre studyChiara Tani, Dina Zucchi, Isabell Haase, et al.
Journal of Autoimmunity|September 23, 2017
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide studyLuca Iaccarino, Laura Andreoli, Elena Bartoloni Bocci, et al.
Lupus|December 17, 2021
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)Xin Wang, Elena Gkrouzman, Danieli Castro Oliveira Andrade, et al.
Arthritis Care & Research|September 28, 2020
Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and RepositoryEcem Sevim, Diane Zisa, Danieli Andrade, et al.
Reumatismo|February 13, 2025
The Italian Society for Rheumatology guidelines on reproductive health in patients with rheumatic diseasesChiara Crotti, Nicola Ughi, Emanuela Beretta, et al.
Pageof 12

Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Frontiers in Immunology|May 18, 2026
Anti-β2GPI IgG display a broad reactivity against different β2GPI domains beyond domain 1: results from the APS ACTION and multi-center Italian cohortsClaudia Grossi, Caterina Bodio, Suresh Kumar, et al.
Frontiers in Immunology|April 27, 2026
Correction: A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registryAlexander Pine, Ayesha Butt, Laura Andreoli, et al.
Frontiers in Immunology|November 3, 2025
A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registryAlexander Pine, Ayesha Butt, Laura Andreoli, et al.
Frontiers in Immunology|June 11, 2026
Correction: Anti-β2GPI IgG display a broad reactivity against different β2GPI domains beyond domain 1: results from the APS ACTION and multi-center Italian cohortsClaudia Grossi, Caterina Bodio, Suresh Kumar, et al.
Arthritis Care & Research|April 19, 2018
The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and RepositoryOzan Unlu, Doruk Erkan, Medha Barbhaiya, et al.
Lupus Science & Medicine|June 14, 2022
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre studyChiara Tani, Dina Zucchi, Isabell Haase, et al.
Journal of Autoimmunity|September 23, 2017
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide studyLuca Iaccarino, Laura Andreoli, Elena Bartoloni Bocci, et al.
Lupus|December 17, 2021
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)Xin Wang, Elena Gkrouzman, Danieli Castro Oliveira Andrade, et al.
Arthritis Care & Research|September 28, 2020
Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and RepositoryEcem Sevim, Diane Zisa, Danieli Andrade, et al.
Reumatismo|February 13, 2025
The Italian Society for Rheumatology guidelines on reproductive health in patients with rheumatic diseasesChiara Crotti, Nicola Ughi, Emanuela Beretta, et al.
Pageof 12